-
1دورية أكاديمية
المؤلفون: Wang H; Department of Radiation Oncology, Xiaolan People's Hospital of Zhongshan (The Fifth People's Hospital of ZhongShan), No. 65, Jucheng Rd. Xiaolan Dist. 528415, Zhongshan, Guangdong Prov., China. Electronic address: wanghui19901118@outlook.com., Hu L; Department of Thoracic Oncology, the Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, China., Zhang F; Department of Radiation Oncology, Xiaolan People's Hospital of Zhongshan (The Fifth People's Hospital of ZhongShan), No. 65, Jucheng Rd. Xiaolan Dist. 528415, Zhongshan, Guangdong Prov., China., Fang M; Department of Radiation Oncology, Xiaolan People's Hospital of Zhongshan (The Fifth People's Hospital of ZhongShan), No. 65, Jucheng Rd. Xiaolan Dist. 528415, Zhongshan, Guangdong Prov., China., Xu J; Department of Radiation Oncology, Xiaolan People's Hospital of Zhongshan (The Fifth People's Hospital of ZhongShan), No. 65, Jucheng Rd. Xiaolan Dist. 528415, Zhongshan, Guangdong Prov., China., Li M; Department of Radiation Oncology, Xiaolan People's Hospital of Zhongshan (The Fifth People's Hospital of ZhongShan), No. 65, Jucheng Rd. Xiaolan Dist. 528415, Zhongshan, Guangdong Prov., China., Chen Z; Department of Radiation Oncology, Xiaolan People's Hospital of Zhongshan (The Fifth People's Hospital of ZhongShan), No. 65, Jucheng Rd. Xiaolan Dist. 528415, Zhongshan, Guangdong Prov., China.
المصدر: Oral oncology [Oral Oncol] 2024 Jun; Vol. 153, pp. 106814. Date of Electronic Publication: 2024 May 06.
نوع المنشور: Journal Article; Meta-Analysis; Systematic Review; Review
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Vascular Endothelial Growth Factor A*/antagonists & inhibitors , Receptors, Vascular Endothelial Growth Factor*/antagonists & inhibitors , Squamous Cell Carcinoma of Head and Neck*/drug therapy, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/adverse effects ; B7-H1 Antigen/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Head and Neck Neoplasms/drug therapy ; Male ; Female
-
2دورية أكاديمية
المؤلفون: Sun BY; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Zhang D; Department of Hepatic Oncology, Xiamen Clinical Research Center for Cancer Therapy, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, 361015, China.; Department of Hepatic Oncology, Liver Cancer Institute, Key Laboratory for Carcinogenesis and Cancer Invasion (Ministry of Education), Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Gan W; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Wu JF; Department of Hepatic Oncology, Xiamen Clinical Research Center for Cancer Therapy, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, 361015, China.; Department of Hepatic Oncology, Liver Cancer Institute, Key Laboratory for Carcinogenesis and Cancer Invasion (Ministry of Education), Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Wang ZT; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Sun GQ; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Zhou J; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Fan J; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Yi Y; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Hu B; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. hu.bo@zs-hospital.sh.cn., Zhang BH; Department of Hepatic Oncology, Xiamen Clinical Research Center for Cancer Therapy, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, 361015, China. zhang.boheng@zs-hospital.sh.cn.; Department of Hepatic Oncology, Liver Cancer Institute, Key Laboratory for Carcinogenesis and Cancer Invasion (Ministry of Education), Zhongshan Hospital, Fudan University, Shanghai, 200032, China. zhang.boheng@zs-hospital.sh.cn., Qiu SJ; Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. qiu.shuangjian@zs-hospital.sh.cn.
المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Jul 13; Vol. 150 (7), pp. 348. Date of Electronic Publication: 2024 Jul 13.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Cholangiocarcinoma*/drug therapy , Cholangiocarcinoma*/pathology , Cholangiocarcinoma*/immunology , 5'-Nucleotidase*/antagonists & inhibitors , 5'-Nucleotidase*/metabolism , Bile Duct Neoplasms*/drug therapy , Bile Duct Neoplasms*/pathology , Bile Duct Neoplasms*/immunology , Bile Duct Neoplasms*/metabolism , Immune Checkpoint Inhibitors*/pharmacology , Programmed Cell Death 1 Receptor*/antagonists & inhibitors, Animals ; Mice ; Humans ; GPI-Linked Proteins/antagonists & inhibitors ; GPI-Linked Proteins/metabolism ; Xenograft Model Antitumor Assays ; Cell Line, Tumor ; Disease Progression
-
3دورية أكاديمية
المؤلفون: Li J; Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China., Dan W; Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China., Zhang C; Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China., Liu N; Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China., Wang Y; Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China., Liu J; Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China., Zhang S; Digestive Disease Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, People's Republic of China.
المصدر: Drug design, development and therapy [Drug Des Devel Ther] 2024 Jul 09; Vol. 18, pp. 2847-2868. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE
مواضيع طبية MeSH: Berberine*/pharmacology , Berberine*/chemistry , Toll-Like Receptor 4*/metabolism , Toll-Like Receptor 4*/antagonists & inhibitors , Hypoxia-Inducible Factor 1, alpha Subunit*/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit*/antagonists & inhibitors , NF-kappa B*/metabolism , NF-kappa B*/antagonists & inhibitors , Colitis, Ulcerative*/drug therapy , Colitis, Ulcerative*/metabolism , Colitis, Ulcerative*/chemically induced , Colitis, Ulcerative*/pathology , Computational Biology*, Animals ; Mice ; Humans ; Molecular Docking Simulation ; Lipopolysaccharides/pharmacology ; Lipopolysaccharides/antagonists & inhibitors ; Male ; Dextran Sulfate ; Mice, Inbred C57BL ; Disease Models, Animal ; Network Pharmacology
-
4دورية أكاديمية
المؤلفون: Liang C; School of Biological and Pharmaceutical Sciences, Shaanxi University of Science & Technology, Xi'an, 710021, China; Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Research of Xi'an, Xi'an, 710021, China. Electronic address: chengyuanliang@gmail.com., Zhou Y; School of Biological and Pharmaceutical Sciences, Shaanxi University of Science & Technology, Xi'an, 710021, China; Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Research of Xi'an, Xi'an, 710021, China., Xin L; School of Biological and Pharmaceutical Sciences, Shaanxi University of Science & Technology, Xi'an, 710021, China; Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Research of Xi'an, Xi'an, 710021, China., Kang K; School of Biological and Pharmaceutical Sciences, Shaanxi University of Science & Technology, Xi'an, 710021, China; Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Research of Xi'an, Xi'an, 710021, China., Tian L; Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Research of Xi'an, Xi'an, 710021, China; College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science& Technology, Xi'an, 710021, China., Zhang D; Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Research of Xi'an, Xi'an, 710021, China; Shaanxi Panlong Pharmaceutical Group Co., Ltd., Xi'an, 710025, China., Li H; School of Biological and Pharmaceutical Sciences, Shaanxi University of Science & Technology, Xi'an, 710021, China; Shaanxi Pioneer Biotech Co., Ltd., Xi'an, 710082, China., Zhao Q; School of Biological and Pharmaceutical Sciences, Shaanxi University of Science & Technology, Xi'an, 710021, China; Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Research of Xi'an, Xi'an, 710021, China., Gao H; Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Research of Xi'an, Xi'an, 710021, China; Shaanxi Pioneer Biotech Co., Ltd., Xi'an, 710082, China., Shi Z; Department of Urology Surgery Center, The People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, 830002, China.
المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2024 Jul 05; Vol. 273, pp. 116504. Date of Electronic Publication: 2024 May 18.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE
مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/pathology , Neoplasms*/metabolism , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/chemical synthesis , Cell Cycle Proteins*/antagonists & inhibitors , Cell Cycle Proteins*/metabolism , Protein Serine-Threonine Kinases*/antagonists & inhibitors , Protein Serine-Threonine Kinases*/metabolism, Humans ; Structure-Activity Relationship ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Protein-Tyrosine Kinases/metabolism ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/chemistry ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/pharmacology ; Small Molecule Libraries/chemical synthesis ; Patents as Topic ; Molecular Structure
-
5دورية أكاديمية
المؤلفون: Yang Q; Department of Oncology and Hematology, People's Hospital of Leshan, 2-428 Yong'an Road, Leshan, 614000, Sichuan, People's Republic of China. yq670523405@126.com., Li Q; Department of General Medical, People's Hospital of Leshan, Leshan, 614000, People's Republic of China., Fan H; Department of Oncology and Hematology, People's Hospital of Leshan, 2-428 Yong'an Road, Leshan, 614000, Sichuan, People's Republic of China.
المصدر: Archives of dermatological research [Arch Dermatol Res] 2024 Jul 03; Vol. 316 (7), pp. 447. Date of Electronic Publication: 2024 Jul 03.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X (Electronic) Linking ISSN: 03403696 NLM ISO Abbreviation: Arch Dermatol Res Subsets: MEDLINE
مواضيع طبية MeSH: Quinolines*/pharmacology , Quinolines*/therapeutic use , Quinolines*/administration & dosage , Melanoma*/drug therapy , Melanoma*/pathology , Neovascularization, Pathologic*/drug therapy , Neovascularization, Pathologic*/pathology , Indoles*/pharmacology , Indoles*/therapeutic use , Xenograft Model Antitumor Assays* , Cell Proliferation*/drug effects , Human Umbilical Vein Endothelial Cells* , Vascular Endothelial Growth Factor Receptor-2*/metabolism , Vascular Endothelial Growth Factor Receptor-2*/antagonists & inhibitors , Cell Movement*/drug effects, Humans ; Animals ; Mice ; Cell Line, Tumor ; Receptor, Fibroblast Growth Factor, Type 1/metabolism ; Receptor, Fibroblast Growth Factor, Type 1/antagonists & inhibitors ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Signal Transduction/drug effects ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Angiogenesis Inhibitors/pharmacology ; Angiogenesis Inhibitors/administration & dosage ; Angiogenesis Inhibitors/therapeutic use ; Receptor, Platelet-Derived Growth Factor beta/metabolism ; Receptor, Platelet-Derived Growth Factor beta/antagonists & inhibitors ; Mice, Nude ; Angiogenesis
-
6دورية أكاديمية
المؤلفون: Wang W; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Xiong H; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Li L; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Hu X; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Zhuang W; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Li J; Zhejiang University, School Medicine, Affiliated Hospital 2, Department of Surgery, Hangzhou 310009, China., Sun X; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Yu Y; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Yu Y; Zhejiang University, School Medicine, Affiliated Hospital 2, Department of Surgery, Hangzhou 310009, China., Guo Y; Zhejiang University, School Medicine, Affiliated Hospital 2, Department of Surgery, Hangzhou 310009, China., Wang Y; Zhejiang University, School Medicine, Affiliated Hospital 2, Department of Surgery, Hangzhou 310009, China., Wang R; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Wang H; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China., Li Q; College of Pharmaceutical Sciences, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Key Laboratory of Marine Fishery Resources Exploitment, Zhejiang Province, China. Electronic address: liqy@zjut.edu.cn.
المصدر: Bioorganic chemistry [Bioorg Chem] 2024 Jul; Vol. 148, pp. 107436. Date of Electronic Publication: 2024 May 08.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2120 (Electronic) Linking ISSN: 00452068 NLM ISO Abbreviation: Bioorg Chem Subsets: MEDLINE
مواضيع طبية MeSH: Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/pathology , Pancreatic Neoplasms*/metabolism , Camptothecin*/pharmacology , Camptothecin*/chemistry , Proto-Oncogene Proteins c-akt*/metabolism , Proto-Oncogene Proteins c-akt*/antagonists & inhibitors , TOR Serine-Threonine Kinases*/metabolism , TOR Serine-Threonine Kinases*/antagonists & inhibitors , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/chemical synthesis , Cell Proliferation*/drug effects , Drug Screening Assays, Antitumor* , Apoptosis*/drug effects, Humans ; Animals ; Mice ; Structure-Activity Relationship ; Molecular Structure ; Dose-Response Relationship, Drug ; Pyruvate Dehydrogenase Acetyl-Transferring Kinase/antagonists & inhibitors ; Pyruvate Dehydrogenase Acetyl-Transferring Kinase/metabolism ; Mice, Nude ; Tumor Cells, Cultured ; Cell Line, Tumor
-
7دورية أكاديمية
المؤلفون: Jiang ZP; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Su R; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Chen MT; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Li JY; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Chen HY; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Yang L; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Liu FF; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Liu J; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Xu CJ; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China., Li WS; Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education and Key Laboratory of Tropical Medicinal Plant Chemistry of Hainan Province, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou, 571158, China. Electronic address: mimowanshan@163.com., Rao Y; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China. Electronic address: raoyong@hainanu.edu.cn., Huang L; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570200, China. Electronic address: Linghuang@hainanu.edu.cn.
المصدر: Phytochemistry [Phytochemistry] 2024 Jul; Vol. 223, pp. 114121. Date of Electronic Publication: 2024 May 01.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 0151434 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3700 (Electronic) Linking ISSN: 00319422 NLM ISO Abbreviation: Phytochemistry Subsets: MEDLINE
مواضيع طبية MeSH: Lipopolysaccharides*/pharmacology , Lipopolysaccharides*/antagonists & inhibitors , Sesquiterpenes, Eudesmane*/pharmacology , Sesquiterpenes, Eudesmane*/chemistry , Sesquiterpenes, Eudesmane*/isolation & purification , Anti-Inflammatory Agents*/pharmacology , Anti-Inflammatory Agents*/chemistry , Anti-Inflammatory Agents*/isolation & purification , Microglia*/drug effects, Animals ; Mice ; Molecular Structure ; Nitric Oxide/biosynthesis ; Nitric Oxide/antagonists & inhibitors ; Structure-Activity Relationship ; NF-kappa B/antagonists & inhibitors ; NF-kappa B/metabolism ; Dose-Response Relationship, Drug ; Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Anti-Inflammatory Agents, Non-Steroidal/chemistry ; Anti-Inflammatory Agents, Non-Steroidal/isolation & purification ; Sesquiterpenes/pharmacology ; Sesquiterpenes/chemistry ; Sesquiterpenes/isolation & purification
-
8دورية أكاديمية
المؤلفون: Genovese M; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli (NA), Italy., Galietta LJV; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli (NA), Italy; Department of Translational Medical Sciences (DISMET), University of Naples 'Federico II', Italy. Electronic address: l.galietta@tigem.it.
المصدر: Cell calcium [Cell Calcium] 2024 Jul; Vol. 121, pp. 102905. Date of Electronic Publication: 2024 May 10.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8006226 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1991 (Electronic) Linking ISSN: 01434160 NLM ISO Abbreviation: Cell Calcium Subsets: MEDLINE
مواضيع طبية MeSH: Anoctamin-1*/metabolism , Anoctamin-1*/antagonists & inhibitors, Humans ; Animals ; Anoctamins/metabolism ; Chloride Channels/metabolism ; Chloride Channels/antagonists & inhibitors ; Neoplasm Proteins/metabolism ; Neoplasm Proteins/antagonists & inhibitors ; Phospholipid Transfer Proteins/metabolism ; Phospholipid Transfer Proteins/antagonists & inhibitors
-
9دورية أكاديمية
المؤلفون: Onuora S; Nature Reviews Rheumatology, . nrrheum@nature.com.
المصدر: Nature reviews. Rheumatology [Nat Rev Rheumatol] 2024 Jul; Vol. 20 (7), pp. 396.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101500080 Publication Model: Print Cited Medium: Internet ISSN: 1759-4804 (Electronic) Linking ISSN: 17594790 NLM ISO Abbreviation: Nat Rev Rheumatol Subsets: MEDLINE
مواضيع طبية MeSH: Adaptor Proteins, Signal Transducing*/antagonists & inhibitors , Adaptor Proteins, Signal Transducing*/metabolism , Bone Morphogenetic Proteins*/antagonists & inhibitors , Bone Morphogenetic Proteins*/metabolism , Signal Transduction*/drug effects, Humans ; Genetic Markers ; Animals ; Receptor, Platelet-Derived Growth Factor beta/antagonists & inhibitors ; Receptor, Platelet-Derived Growth Factor beta/metabolism
-
10دورية أكاديمية
المؤلفون: Li BY; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China., Li P; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China., Wei LY; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China., Zou J; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China., Wang YH; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China., You QD; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China., Jiang C; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China., Di B; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China., Xu LL; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China.
المصدر: Journal of medicinal chemistry [J Med Chem] 2024 Jun 27; Vol. 67 (12), pp. 9869-9895. Date of Electronic Publication: 2024 Jun 18.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
مواضيع طبية MeSH: NLR Family, Pyrin Domain-Containing 3 Protein*/antagonists & inhibitors , NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism , NIMA-Related Kinases*/antagonists & inhibitors , NIMA-Related Kinases*/metabolism , Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/metabolism , Arthritis, Experimental*/drug therapy, Animals ; Humans ; Rats ; Drug Discovery ; Structure-Activity Relationship ; Male ; Inflammasomes/metabolism ; Inflammasomes/antagonists & inhibitors ; Molecular Docking Simulation ; Antirheumatic Agents/pharmacology ; Antirheumatic Agents/chemistry ; Antirheumatic Agents/chemical synthesis ; Antirheumatic Agents/therapeutic use